These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24451141)

  • 1. Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes.
    Hu B; Zhang Y; Zeng Q; Han Q; Zhang L; Liu M; Li X
    Int J Mol Sci; 2014 Jan; 15(1):1606-24. PubMed ID: 24451141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CTGF in the diabetic rat retina and its relationship with VEGF and TGF-β(2) , elucidated by treatment with CTGFsiRNA.
    Yang H; Huang Y; Chen X; Liu J; Lu Y; Bu L; Xia L; Xiao W; Chen M; Nie Q; Liu Z
    Acta Ophthalmol; 2010 Sep; 88(6):652-9. PubMed ID: 20039857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of connective tissue growth factor by small interfering ribonucleic acid prevents increase in extracellular matrix molecules in a rodent model of diabetic retinopathy.
    Winkler JL; Kedees MH; Guz Y; Teitelman G
    Mol Vis; 2012; 18():874-86. PubMed ID: 22511849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.
    Van Geest RJ; Lesnik-Oberstein SY; Tan HS; Mura M; Goldschmeding R; Van Noorden CJ; Klaassen I; Schlingemann RO
    Br J Ophthalmol; 2012 Apr; 96(4):587-90. PubMed ID: 22289291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes.
    Li T; Hu J; Du S; Chen Y; Wang S; Wu Q
    Mol Vis; 2014; 20():1109-21. PubMed ID: 25324681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an intravitreal injection of bevacizumab on the expression of VEGF and CD34 in the retina of diabetic rats.
    Ma J; Zhu T; Tang X; Ye P; Zhang Z
    Clin Exp Ophthalmol; 2010 Dec; 38(9):875-84. PubMed ID: 20653693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1.
    Sohn EH; He S; Kim LA; Salehi-Had H; Javaheri M; Spee C; Dustin L; Hinton DR; Eliott D
    Arch Ophthalmol; 2012 Sep; 130(9):1127-34. PubMed ID: 22965588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B; Sun JH; Xiang FF; Liu L; Li WJ
    Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of simvastatin on expression of connective tissue growth factor in vitreous and retina of diabetic rats].
    Hu YB; Zhang JK; Sun ZY; Liu YM; Yan H
    Zhonghua Yan Ke Za Zhi; 2012 May; 48(5):444-9. PubMed ID: 22932337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats.
    Zhu Y; Zhang XL; Zhu BF; Ding YN
    Mol Biol Rep; 2012 Apr; 39(4):3727-35. PubMed ID: 21952821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes.
    Li J; Wang P; Ying J; Chen Z; Yu S
    Cell Physiol Biochem; 2016; 39(3):1196-208. PubMed ID: 27595397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
    Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
    Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
    Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
    Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats.
    Huang J; Li X; Li M; Li S; Xiao W; Chen X; Cai M; Wu Q; Luo D; Tang S; Luo Y
    Diabetes Obes Metab; 2012 Jul; 14(7):644-53. PubMed ID: 22340191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway.
    Zhang B; Zhou KK; Ma JX
    Diabetes; 2010 Jul; 59(7):1809-16. PubMed ID: 20299474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor-A
    Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
    Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina.
    Kuiper EJ; Hughes JM; Van Geest RJ; Vogels IM; Goldschmeding R; Van Noorden CJ; Schlingemann RO; Klaassen I
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4267-76. PubMed ID: 17724216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
    Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
    Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.